HCV kinetics and behaviour of HCV-specific CD8-mediated responses under anti-viral therapy.

被引：0

作者：

Missale, G

Pilli, M

Zerbini, A

Penna, A

Orlandini, A

Hagai, E

von Wagner, M

Arvanitakis, C

Lurie, Y

Esteban, JI

Haagmanns, B

Hezode, C

Lagging, M

Negro, F

Soulier, A

Homburger, Y

Pawlotsky, JM

Zeuzem, S

Shalm, SW

Neumann, AU

Ferrari, C

机构：

[1] Azienda Osped, Parma, Italy

[2] Bar Ilan Univ, Ramat Gan, Israel

[3] Saarland Univ Hosp, Homburg, Germany

[4] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece

[5] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

[6] Hosp Gen Valle Hebron, Barcelona, Spain

[7] Univ Rotterdam Hosp, Rotterdam, Netherlands

[8] Univ Paris 12, Hop Henri Mondor, Paris, France

[9] Univ Goeteborg, Goeteborg, Sweden

[10] Univ Hosp Geneva, Geneva, Switzerland

来源：

HEPATOLOGY | 2004年 / 40卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：438A / 439A

页数：2

共 50 条

[21] The functional and molecular determinants of HCV-specific CD8 T cell responses during early infection
Cai, Curtis
Samir, Jerome
Adikari, Thiruni
Peters, Tim
Luciani, Fabio
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
[22] Hcv-specific CD4+ and CD8+ T cell responses in HCV-recovered individuals: Significance of comprehensive testing using overlapping peptides
Kubitschke, A
Klade, C
Meyer, M
Zauner, W
Lehmann, M
Aslan, N
Zinke, S
Wiegand, J
Manns, MP
Wedemeyer, H
JOURNAL OF HEPATOLOGY, 2005, 42 : 161 - 161
[23] Function is the key: impact of interferon on HCV-specific CD8+ T cells during acute HCV infection
Bengsch, Bertram
Thimme, Robert
FUTURE VIROLOGY, 2008, 3 (06) : 537 - 542
[24] Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor β that can suppress HCV-specific T-cell responses
Alatrakchi, Nadia
Graham, Camilla S.
van der Vliet, Hans J. J.
Sherman, Kenneth E.
Exley, Mark A.
Koziel, Margaret James
JOURNAL OF VIROLOGY, 2007, 81 (11) : 5882 - 5892
[25] Association of HCV-specific γ-interferon producing CD8+ T cells with viral clearance in acute hepatitis C
Gruener, NH
Gerlach, JT
Jung, MC
Diepolder, HM
Zachoval, R
Hoffmann, R
Schraut, W
Schirren, CA
Santantonio, T
Pape, GR
HEPATOLOGY, 1998, 28 (04) : 320A - 320A
[26] ANTI-VIRAL THERAPY IN HAEMODIALYZED HCV PATIENTS: EFFICACY, TOLERANCE AND TREATMENT STRATEGY
Deltenre, P.
Thabut, D.
Tran, A.
Moreno, C.
Castel, H.
El Nady, M.
Canva, V.
Louvet, A.
Ben Ali, H.
Provot, F.
Glowacki, F.
Dharancy, S.
Stanke, F.
Henrion, J.
Noel, C.
Mathurin, P.
JOURNAL OF HEPATOLOGY, 2009, 50 : S223 - S223
[27] ANTI-VIRAL THERAPY IN HAEMODIALYZED HCV PATIENTS: EFFICACY, TOLERANCE AND TREATMENT STRATEGY
Deltenre, Pierre
Thabut, Dominique
Tran, Albert
Castel, Helene
El Nady, Mohamed
Canva, Valerie
Louvet, Alexandre
Ben Ali, Houssem
Provot, Francois
Glowacki, Francois
Dharancy, Sebastien
Stanke, Francoise
Henrion, Jean
Noel, Christian
Mathurin, Philippe
HEPATOLOGY, 2008, 48 (04) : 851A - 852A
[28] Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy
Deltenre, P.
Moreno, C.
Tran, A.
Ollivier, I.
Provot, F.
Stanke, F.
Lazrek, M.
Castel, H.
Canva, V.
Louvet, A.
Colin, M.
Glowacki, F.
Dharancy, S.
Henrion, J.
Hazzan, M.
Noel, C.
Mathurin, P.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (04) : 454 - 461
[29] Virological and histopathological efficacy of anti-viral therapy in HCV-related cirrhosis
Pichard, AV
Nalpas, B
Fontaine, H
Chaix, ML
Carnot, F
Brechot, C
Pol, S
JOURNAL OF HEPATOLOGY, 2002, 36 : 243 - 243
[30] Comprehensive analysis of the HCV-specific CD8+T cell response in individuals with chronic or resolved HCV infection.
Lauer, GM
Nguyen, TN
Day, CL
Klenerman, P
Chung, RT
Walker, BD
HEPATOLOGY, 2001, 34 (04) : 432A - 432A

← 1 2 3 4 5 →